Used in pharmaceutical research as a potent inhibitor of kinases involved in cancer cell proliferation. Shows promising activity in suppressing tumor growth by targeting specific signaling pathways in oncology studies. Also investigated for its anti-inflammatory properties due to modulation of cellular kinase activity. Serves as a key intermediate in the synthesis of indazolyl-based therapeutic agents. Its bromophenyl and pyridinyl groups enhance binding selectivity, making it valuable in structure-activity relationship (SAR) studies for drug design.